Atlas Trials

A Phase I Study: PET Imaging of Cancer Patients Using [18F] 4-L-Fluoroglutamine (2S,4R)

Clinical trial NCT01697930 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT01697930
Sponsor
Memorial Sloan Kettering Cancer Center
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Solid MalignancyLymphoma
Start date
2012-09-01
Primary completion
2026-09-01
Enrollment
67

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.